Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X about a paper she co-authored with colleagues published in European Urology:
“Words of Wisdom just published in European Urology:
- Exercise post chemo cuts recurrence by 28%/mortality by 37% in the CHALLENGE colon cancer trial.
- Time to treat physical activity as a systemic anticancer therapy. Exercisumab also in urologic oncology and exercise oncology.”
Title: Re: Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
Authors: Sabine D. Brookman-May, Shimon Kempin, Benazir Enzinger
You can read the Full Article on European Urology.
More posts featuring Sabine D. Brookman-May.
